Fluoxetine Succinamic Acid(1026723-45-4)
- Name: Fluoxetine Succinamic Acid
- Synonyms:Fluoxetine Succinamic Acid;4-[Methyl[3-phenyl-3-[4-(trifluoroMethyl)phenoxy]propyl]aMino]-4-oxobutanoic Acid;N-Methyl-N-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-succinamic acid
- Molecular Formula:C21H22F3NO4
- Molecular Weight:426.4294096
- CAS Registry Number:1026723-45-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1026723-45-4 3-[methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})carbamoyl]propanoic acid
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.1026723-45-4 Fluoxetine succinamic acid
Assay:98%Min Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by ocean shipping or clients requirement Application:An important raw material and intermediate used in Organic Synthesis, Pharmaceuticals
Min. Order:0
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)] CAS No.1026723-45-4 Fluoxetine EP Impurity C HCl (Fluoxetine USP Related Compound A HCl)
Assay:95%+ or 98%+ Application:for drug impurity for drug standards,for drug research and development銆侱rug impurity reference, drug standard, analytical chemistry, standard substance, organic chemical synthesis, chemical custo...
Min. Order:25Milligram
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.1026723-45-4 Fluoxetine Succinamic Acid
Assay:97% Appearance:crystalline powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 1346698-16-5/3,4-dichloro-5-(cyclobutylmethoxy)pyridazine
- 199926-39-1/CHELIDAMIC ACID MONOHYDRATE, 98
- 462067-46-5/3-((2-hydroxyethylamino)methyl)-6,8-dimethylquinolin-2(1H)-one
- 1142215-84-6/((4-methoxyphenyl){2-oxo-2-[(2-pyridin-2-ylethyl)amino]ethyl}amino)acetic acid
- 1263051-28-0/4-(cyclohexylmethoxy)-3-(thiophen-2-yl)quinolin-2(1H)-one
- 1211532-15-8/6-Methoxy-5-(trifluoromethyl)nicotinic acid
- 5140-36-3/9-(Acetyloxy)-1,2,10-trimethoxy-7H-dibenzo[de,g]quinolin-7-one
- 35582-21-9/3-(4-thiazolyl)phenol
- 220364-91-0/(1,4-diazepan-6-yl)methanol
- 378764-69-3/SALOR-INT L246247-1EA
- 791125-43-4/Benzamide, N-(4-cyanophenyl)-4-ethyl- (9CI)
- 173065-76-4/Benzoic acid, 4-[3-(acetyloxy)-2-methylpropyl]-, methyl ester, (R)- (9CI)
- 29434-03-5/1,2-Propandiol,polymer with methyl oxirane
- 531547-17-8/3,5-DIBROMO-2-[[[[[5-(4-BROMOPHENYL)-2-FURANYL]CARBONYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
- 851895-79-9/(3beta)-17-(1H-Benzimidazol-1-yl)androsta-5,16-dien-3-ol 3-acetate
- 3519-82-2/9,10-DIHYDRO-9,10[1',2']-BENZENOANTHRACENE-1,4-DIONE
- 605639-75-6/4-Piperidinecarboxamide,N-[(4-fluorophenyl)methyl]-1-pyrazinyl-(9CI)
- 898793-65-2/2'-CYANO-3-(2,4-DIMETHYLPHENYL)PROPIOPHENONE
- 909666-37-1/1-BENZYL-4-([6-(TRIFLUOROMETHYL)PYRIDIN-3-YL]METHYL)-1,4-DIAZEPANE
- 1026723-45-4/Fluoxetine Succinamic Acid
- 1141886-66-9/(3-exo)-8-Methyl-8-azabicyclo[3.2.1]octane-3-thiol hydrochloride
- 126215-84-7/Pyrimidine, 2-(4-pentynyl)- (9CI)
- 478251-30-8/SALOR-INT L212393-1EA
- 4181-32-2/1-(5,8-dimethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethanone
- 618070-39-6/SALOR-INT L201243-1EA
- 65527-16-4/(24Z)-3α,5-Cyclo-5α-stigmast-24(28)-en-6β-ol
- 74875-16-4/1,2-bis(2,6-dichloro-4-nitrophenyl)disulfane
- 792880-39-8/4-(3-CHLORO-4-FLUOROPHENYL)-2(3H)-THIAZOLONE HYDRAZONE
- 86882-92-0/Ethyl 3-aMino-5,6-dichloropyrazine-2-carboxylate
- 942070-20-4/2-(2,5-DiMethylthiophen-3-yl)-4,4,5,5-tetraMethyl-1,3,2-dioxaborolane